文献速递流行病学与生物统计

全或无依从性临床试验疗效的合成估计量

A synthetic estimator for the efficacy of clinical trials with all-or-nothing compliance.
PubMed 文献 · Stat Med · 2017-08-18

针对二分类治疗且全或无依从性的临床试验,现有工具变量、符合方案和实际治疗三种估计量各有局限。作者提出一种非参数的合成估计量,为三者的线性凸组合,可适用于多种结局类型。该方法应用于一项创伤后应激障碍临床试验。

要点

  • 全或无依从性下,工具变量估计量可能无偏但变异极大。
  • 符合方案和实际治疗估计量通常更有效但可能受选择偏倚影响。
  • 合成估计量为三种估计量的线性凸组合,无需特定分布假设。

核心结论

  • 作者提出一种数据驱动的合成估计量,为工具变量、符合方案和实际治疗估计量的线性凸组合,且为非参数方法。

研究设计与样本

  • 方法学研究,提出合成估计量并用简单正态混合分布解析形式构建,应用于一项创伤后应激障碍临床试验。

主要发现

  • 工具变量估计量可能无偏但在许多情形下变异极大,符合方案和实际治疗估计量通常更有效但可能受选择偏倚影响。
  • 合成估计量为三种估计量的线性凸组合,类似模型平均法,但为非参数方法,适用于多种结局类型而无需特定分布假设。
  • 将合成方法应用于一项创伤后应激障碍临床试验。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

A critical issue in the analysis of clinical trials is patients' noncompliance to assigned treatments. In the context of a binary treatment with all or nothing compliance, the intent-to-treat analysis is a straightforward approach to estimating the effectiveness of the trial. In contrast, there exist 3 commonly used estimators with varying statistical properties for the efficacy of the trial, formally known as the complier-average causal effect. The instrumental variable estimator may be unbiased but can be extremely variable in many settings. The as treated and per protocol estimators are usually more efficient than the instrumental variable estimator, but they may suffer from selection bias. We propose a synthetic approach that incorporates all 3 estimators in a data-driven manner. The synthetic estimator is a linear convex combination of the instrumental variable, per protocol, and as treated estimators, resembling the popular model-averaging approach in the statistical literature. However, our synthetic approach is nonparametric; thus, it is applicable to a variety of outcome types without specific distributional assumptions. We also discuss the construction of the synthetic estimator using an analytic form derived from a simple normal mixture distribution. We apply the synthetic approach to a clinical trial for post-traumatic stress disorder.

来源:Stat Med,查看原文。版权归原作者所有。

引用

  1. Antonelli J, Han B, Cefalu M, et al. A synthetic estimator for the efficacy of clinical trials with all-or-nothing compliance. Stat Med. 2017. PMID: 28833307. doi:10.1002/sim.7447

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。